Standards of ethics at the National Institute of Health

Article Abstract:

The federal government has banned payments by drug companies to any employee of the National Institutes of Health (NIH) and has implemented broad restrictions on employees' outside activities and financial arrangements, including the holding of stock in biotechnology and pharmaceutical companies and acceptance of prizes. The NIH includes 27 institutes and centers, has an annual budget of about $28 billion, and is widely regarded as the world's premier biomedical research institution.

Research & Development, Scientific Research and Development Services, Pharmaceutical preparations, Research & Development NEC, Pharmaceutical industry, Research institutes, United States. National Institutes of Health

---

Nonpayment for performance? Medicare's new reimbursement rule

Article Abstract:

The Centers for Medicare and Medicaid Services (CMS) decided to start giving reimbursements for the all the conditions that result due to some medical errors. The rule cannot be easily implemented, as the factors determining such conditions are not clearly identified.

Health Care and Social Assistance, Commodity & service prices, HEALTH SERVICES, Administration of Public Health Programs, Health Care Services, Medical & Health Services, Prices and rates, Complications and side effects, Medical care, Hospitals, Medication errors, Medical care (Private), Company pricing policy, Hospital rates

---

Similar abstracts:

• Abstracts: Shortages of medical personnel at community health centers. Effectiveness of teaching quality improvement to clinicians
• Abstracts: Impact of an adolescent sex education program that was implemented by an academic medical center. Analysis of knowledge and attitudes of adult groups before and after attending an educational representation regarding adolescent sexual activity
• Abstracts: Preventing cervical cancer in the developing world. Letting go of the rope -- aggressive treatment, hospice care, and open access
• Abstracts: Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing: An open-label, Randomized, Multicenter Study (PhenGen)
• Abstracts: Trends in prevalence of HIV, syphilis, hepatitis C, hepatitis B, and sexual risk behavior among men who have sex with men

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.